北米の皮膚科治療薬市場予測2019-2028

◆英語タイトル:NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028
◆商品コード:INK20AG057
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年7月
◆ページ数:117
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe North America dermatological therapeutics market is set to register a CAGR of 7.40% during the forecast period, 2019-2028. The market has earned the principal status, given the exploding rate of skin and pores diseases, along with surging dermatology cases in countries like the US. The country is considered to be the greatest commercial center for dermatology drugs.

MARKET INSIGHTS
The North America dermatological therapeutics market growth evaluation encompasses the analysis of Canada and the United States. In Canada, there is a growing prevalence of psoriasis and other dermatological disorders. The Canadian Association of Psoriasis Patients (CAPP) is a national non-profit organization that focuses on providing resources and championing psoriatic patients and their families for improving patient care and quality of life. About one million people in Canada live with psoriasis, according to the organization’s report of 2018. There is the benefit of increased dermatological treatments as a result of efforts from both, government and non-government organizations in Canada. There is an expansion of market players in the country with new product launches, acquisitions, and collaborations. Amgen Canada received the approval in February 2020 for market authorization transfer of Celgene Corporation’s OTEZLA. The only restraining factor of market growth assessed as of now is the ongoing COVID-19 crisis.

COMPETITIVE INSIGHTS
The competitive market entails acquisitions and collaborations by the established players. Some of these include, AbbVie Inc, Allergan Inc, GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISING LOAD OF DERMATOLOGY DISEASES
3.2.2. RISE IN AWARENESS LEVELS OF DISEASE PROGRESSION AND ORIGIN
3.3. KEY RESTRAINTS
3.3.1. SEVERE SIDE EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY DRUG CLASS
5.1. ANTI-INFECTIVES
5.2. CORTICOSTEROIDS
5.3. ANTI-ACNE
5.4. CALCINEURIN INHIBITORS
5.5. RETINOIDS
5.6. OTHER DRUG CLASSES
6. MARKET BY APPLICATION
6.1. ALOPECIA
6.2. HERPES
6.3. PSORIASIS
6.4. ROSACEA
6.5. ATOPIC DERMATITIS
6.6. ACNE VULGARIS
6.7. OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
8. COMPANY PROFILES
8.1. ABBVIE INC
8.2. ALLERGAN INC
8.3. ALMIRAL
8.4. AMGEN INC
8.5. BAUSCH HEALTH COMPANIES INC
8.6. GALDERMA
8.7. GLAXOSMITHKLINE PLC
8.8. JOHNSON & JOHNSON
8.9. NOVARTIS AG
8.10. PFIZER INC
8.11. AGI DERMATICS
8.12. LEO PHARMA A/S
8.13. MERCK KGAA

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - DERMATOLOGICAL THERAPEUTICS
TABLE 2: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 3: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 4: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 5: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 6: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 7: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[北米の皮膚科治療薬市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆